Videos | Page 5

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the range of education and training that prepares pharmacists to play a role in patient-centered diabetes care.
David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses changes in insurance reimbursement for compounded medications.
Shannon Manzi, PharmD, EMT, describes the experience of helping to respond to the Boston Marathon bombing in April 2013.
Sara Anvari, MD, discusses the function of histamine in the immune response and treatment with antihistamines.
Leonard Bielory, MD, reviews challenging cases of ocular allergy and discusses treatment options.
Luz Fonacier, MD, talks about the diagnosis and management of atopic dermatitis.
Jonathan G. Marquess, PharmD, CDE, explains that employers can save a great deal on health care costs by helping their employees with diabetes effectively manage their condition.
Jeff Fudin, PharmD, FCCP, argues that the way to make hydrocodone combination products safer for patients is to provide more education for those who prescribe the medications and pharmacists who dispense them.
Mary Lynn McPherson, PharmD, explains why hydrocodone combination products should no longer be categorized as Schedule III drugs.
Jeff Fudin, PharmD, FCCP, argues that categorizing hydrocodone combination products as Schedule II could lead to increased prescription of codeine, a much “sloppier” drug that could create problems for patients.
Latest Issues